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Editorial on the Research Topic
Controversies in Pediatric Cardiology
There remain many controversies across the spectrum of congenital cardiology which are not
limited to rare diagnoses and uncommonly preformed procedures. Factors contributing to this
include a paucity of randomized trials, the heterogeneous nature of congenital cardiac disease (even
within each headline diagnosis), differences health care systems offering care and an enthusiasm
to carry out new procedures, often related to morbidity and mortality associated with current
strategies. A natural and useful way of addressing and discussing these controversies is as part
of debate sessions at speciality meetings. Although these are often delivered by experts within
that area the total audience is often limited to those attending the meeting. The purpose of this
Research Topic was to extend this debate to print allowing review of more detailed argument and
data presented by the experts to a wider audience.
The three topics considered in this Research Topic are the pulmonary valve replacement for
pulmonary valve regurgitation, the current role of echocardiography in the diagnosis of congenital
heart defects, and the best modality of cardiopulmonary bypass for pediatric heart surgery.
In developed health care systems pulmonary valve replacement is the third most common
procedure in congenital cardiology after atrial septal defect closure and patent ductus arteriosus
closure. Between 2014 and 2017 1,039 such procedures were carried out in the UK (260 in children
and 779 in adults) of which 803 were surgical and 260 transluminal with a reported 30 daymortality
for either procedure of <1%1. Given that this is a high frequency low mortality procedure debate
as to the most appropriate option must also explore morbidity and long term outcomes from
the procedure. In this edition Morgan and Corno present the controversy surrounding whether
pulmonary valve regurgitation should be addressed surgically or interventionally from the point of
view of the interventional cardiologist and the cardiac surgeon.
Morgan explores the rapid developments in both the technique and technology in the field
of percutaneous pulmonary valve implantation. Previous perceived limitations of the procedure
and how these are being addressed are explored. In particular techniques used in the presence
of small right ventricular outflow tracts, including hybrid techniques, and large outflow tracts,
including stents to build landing zones for valve implantation, developments of valve technology
to fill the redundant space, and use of a branch pulmonary artery to secure the some types of
valve. The latest available models of percutaneously implantable valves are described in detail, with
potential advantages and disadvantages to orient the readers in the choice (Morgan). Finally in the
discussion the potential drawbacks and complications are thoroughly analyzed. Specific procedural
complications are discussed including the possibility of conduit rupture, valve embolization,
1https://nicor4.nicor.org.uk/CHD/an_paeds.nsf/vwContent/home (accessed April 28, 2020).
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tricuspid valve damage, and coronary compression as well as how
these can be avoided to give a very low procedural mortality
and morbidity. One of the main concerns about percutaneous
valves, namely the incidence of endocarditis is discussed, with
the suggestion that much of this may be related to the (often
necessary) use of bovine jugular grafts, however these are placed,
and that this will remain a hot topic going forward. The paucity of
high quality long-term data that can be used to directly compare
percutaneously and surgically implanted valves is highlighted as
a major limitation to comparing the two options, in particular
the using “freedom from death or re-intervention” as a the
main comparator.
Corno explores all the currently available options to implant a
pulmonary valve either with direct surgical technique as well as
hybrid approach combining surgical exposure and percutaneous
type of valve implantation, with pros and cons of both types
of choice. The interventionalists might argue that this middle
ground approach demonstrates increasing surgical acceptance
of the percutaneous option! He considers in the decision-
making process the following elements: (a) morphology and
size of the right ventricular outflow tract, in particular in the
presence of a previously implanted trans-annular patch; (b)
morphology and size of the pulmonary arteries in the case a
required enlargement or reconstruction; (c) presence of residual
intra-cardiac defects; (d) presence of extremely dilated and
dysfunctional right ventricle. Clearly the definitive choice will
depend upon the match of the characteristics of the individual
patient with the experience and outcomes of the operators.
Each caregiver has to keep in mind that this type of problem,
pulmonary valve regurgitation, exposes each patient to repeated
procedures during the rest of his/her life, and therefore the choice
has to take in account the options left available for the future
needs (Corno).
With regard to the topic “is echocardiography enough
or cath-angio/CT scan/MRI are still needed?,” the group of
Márquez-González et al. reported a very large study of patients
in Mexico with right ventricular outflow tract obstruction. They
compared the non-invasive approach using the echocardiogram
derived Tei index (defined as the ratio of isovolumetric
contraction time to ejection time) with an invasive cardiac
catheterization definition of right ventricular dysfunction. The
authors provide interesting data that the Tei index in this
group of patients can accurately predict catheterization-based
diagnosis of right ventricular dysfunction (Márquez-González
et al.). Although the limitations of a lack of comparison with
MRI and that catherization-based right ventricular dysfunction
is not synonymous with the need for intervention, the inferences
of this study may be important for low and middle-income
environments where resources are not always available to
perform other imaging modalities.
Finally Corno et al. reported a clinical study with comparison
between two groups of patients homogeneous for age and weight,
with the same STAT risk stratification, operated on for congenital
heart defects, one with normothermic and the other with mild
hypothermic cardiopulmonary bypass. The data collected in
the operating room and during the first 24 post-operative
hours shows that the normothermic group have a favorable
difference in biomarkers (arterial PH, lactate), lower vasoactive
inotropic score, reduced chest drain losses, reduced transfusion
requirement, shorter duration of mechanical ventilation and
shorter stay in Pediatric Intensive Care Unit (PICU). In addition
to the improved immediate clinical outcomes, the normothermic
group had lower average cost per patient day of stay in
PICU (Corno et al.). The authors conclude that wider use
of normothermic cardiopulmonary bypass should be taken
into consideration for pediatric cardiac surgery and suggest
prospective multi-center randomized controlled trials in a risk
adjusted population of patients with complex congenital heart
defects to support their results.
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